Surveillance study reveals a resurgence of norovirus and rotavirus activity under pandemic restrictions, indicating that collateral suppression of viral gastroenteritis is temporary.
A rapid decrease in viral gastroenteritis during winter 2019-20 and a return of norovirus and rotavirus activity during winter 2020-21 were observed while multiple nonpharmaceutical interventions for coronavirus disease were in effect in Hong Kong. The initial collateral benefit of coronavirus disease countermeasures that reduced the viral gastroenteritis burden is not sustainable.
No takes yet. Share an insight, caveat, or question.
Martin C.W. Chan (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: